Trial Details
COMPLETEDBasic Information
| Clinical ID | c122 |
|---|---|
| Identifier | NCT02150551 |
| Trial Title | Safety and Tolerability Of Allogeneic Mesenchymal Stromal Cells in Pediatric Inflammatory Bowel Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Inflammatory Bowel Diseases |
| Interventions | BIOLOGICAL: Allogeneic bone marrow-derived mesenchymal stromal cells |
Participant Information
| Sponsor | Catherine Bollard |
|---|---|
| City | Washington |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2018-06-07 |
|---|---|
| Primary Completion Date | 2018-09-05 |
| Completion Date | 2018-09-05 |